Catalytic Activity of ADAM8, ADAM15, and MDC-L (ADAM28) on Synthetic Peptide Substrates and in Ectodomain Cleavage of CD23
Open Access
- 1 August 2003
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 278 (33), 30469-30477
- https://doi.org/10.1074/jbc.m213157200
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- The Role of ADAM 15 in Glomerular Mesangial Cell MigrationJournal of Biological Chemistry, 2002
- The enzymatic activity of ADAM8 and ADAM9 is not regulated by TIMPsFEBS Letters, 2002
- Catalytic activity of ADAM28FEBS Letters, 2001
- ADAM8: A Novel Osteoclast Stimulating FactorJournal of Bone and Mineral Research, 2001
- TACE and other ADAM proteases as targets for drug discoveryDrug Discovery Today, 2001
- Tumor Necrosis Factor α Induces a Metalloprotease-Disintegrin, ADAM8 (CD 156): Implications for Neuron–Glia Interactions during NeurodegenerationJournal of Neuroscience, 2000
- AntiTNF-α agents in the treatment of inflammationExpert Opinion on Investigational Drugs, 1998
- Specific Interaction of the Recombinant Disintegrin-like Domain of MDC-15 (Metargidin, ADAM-15) with Integrin αvβ3Journal of Biological Chemistry, 1998
- Structure of the Murine CD156 Gene, Characterization of Its Promoter, and Chromosomal LocationPublished by Elsevier ,1997
- CD156 (Human ADAM8): Expression, Primary Amino Acid Sequence, and Gene LocationGenomics, 1997